Japan Tissue Engineering Co., Ltd. (TYO:7774)

Japan flag Japan · Delayed Price · Currency is JPY
628.00
-9.00 (-1.41%)
Jul 22, 2025, 3:30 PM JST
-13.50%
Market Cap25.50B
Revenue (ttm)2.46B
Net Income (ttm)-255.00M
Shares Out40.61M
EPS (ttm)-6.28
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume72,500
Average Volume120,630
Open637.00
Previous Close637.00
Day's Range624.00 - 651.00
52-Week Range361.00 - 780.00
Beta0.19
RSI55.09
Earnings DateJul 30, 2025

About Japan Tissue Engineering

Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it researches and develops human 3-dimensional cultured tissue models for use in... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 204
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 7774
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.